Pages that link to "Q39303759"

The following pages link to Pharyngeal carriage of serogroup W135 Neisseria meningitidis in Hajjees and their family contacts in Morocco, Oman and Sudan (Q39303759):

Displaying 13 items.

• Molecular epidemiology of neisseria meningitidis isolated in the African Meningitis Belt between 1988 and 2003 shows dominance of sequence type 5 (ST-5) and ST-11 complexes (Q34073348) (← links)
• Pharyngeal carriage of Neisseria meningitidis in 2-19-year-old individuals in Uganda (Q34536636) (← links)
• A prospective study of etiology of childhood acute bacterial meningitis, Turkey. (Q34791864) (← links)
• Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine (Q34892719) (← links)
• Carriage of Neisseria meningitidis serogroup W135 ST-2881 (Q35805707) (← links)
• Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135. (Q36600323) (← links)
• Meningococcal carriage in the African meningitis belt (Q37018218) (← links)
• Increase in Meningococcal Serogroup W Disease, Victoria, Australia, 2013-2015. (Q37288188) (← links)
• The prevalence, serogroup distribution and risk factors of meningococcal carriage in adolescents and young adults in Turkey. (Q38989580) (← links)
• Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America (Q42215157) (← links)
• The first large epidemic of meningococcal disease caused by serogroup W135, Burkina Faso, 2002. (Q43932674) (← links)
• Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine (Q56507880) (← links)
• Recent changes in the epidemiology of Neisseria meningitidis serogroup W across the world, current vaccination policy choices and possible future strategies (Q57180910) (← links)